Lovenox Study

Should platelet levels affect use of enoxaparin in DVT prophylactics status post orthopedic arthroplasty?

November 22, 2017

  • Clinical Trial Information

    Trial Contact: Harriott, Paula

    Trial Phone: 321.841.3867

  • IRB No: 14.045.04

    Principal Investigator: George John Haidukewych, MD

    Sub Investigators: Haidukewych, George MD

    Age Group: Adult

    Secondary Protocol No: Lovenox

    Treatment: Medication

    Applicable Disease Sites: Total Hip or Total Knee arthroplasty

    Therapies Involved: Observational study

  • Objective

    To determine whether platelet levels pre- or postoperatively affects the rate of hematoma formation at 1 month and 3 months post-operatively with or without the use of enoxaparin.

  • Key Eligibility

    Patients with preoperative thrombocytopenia.